No Data
UBS Maintains Aveanna Healthcare(AVAH.US) With Sell Rating, Raises Target Price to $3.2
Aveanna Healthcare Holdings Inc. (AVAH) Q3 2024 Earnings Call Transcript Summary
UBS Adjusts Price Target on Aveanna Healthcare to $3.20 From $2.80, Maintains Sell Rating
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Catapults 25% Though Its Price And Business Still Lag The Industry
Express News | Aveanna Healthcare Holdings Inc : Stephens Raises Target Price to $5.50 From $4
Deutsche Bank Maintains Aveanna Healthcare(AVAH.US) With Buy Rating, Raises Target Price to $7
No Data
No Data